We’ve helped third place entrants jump ahead of their second-place competitors, biosimilars jump ahead of their originator targets, expensive orphan drugs get traction when healthcare professionals didn’t see their point.
We’ve seen presentations full of conclusive data fail to move doctors when a simple conversation does.
We’ve worked in almost every specialty of medicine, on every continent, with doctors, nurses, pharmacists, marketers, medical affairs professionals, sales people and MSLs.
We’ve worked on primary care drugs, secondary care drugs, biosimilars, drug device combinations, orphan/ultra-orphan drugs and the very latest personalised medicines.
This keeps us learning every single day but we’ve already gained a good base of knowledge to build on.